NCT04475705View on ClinicalTrials.gov

Propofol vs Sevo for Paediatric Tumor Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Solid TumorCarcinomaMalignancyCancer
Interventions
DRUG

propofol

intravenous propofol using Target Controlled Infusion 'Paedfusor' model 2-5 as the main anaesthetic to achieve Bispectral Index 40-60

DRUG

sevoflurane

sevoflurane at Minimal Alveolar Concentration 0.7-1.3 as the main anaesthetic to achieve Bispectral Index 40-60.

Trial Locations (1)

Unknown

RECRUITING

Hong Kong Children's Hospital, Hong Kong

All Listed Sponsors
collaborator

The University of Hong Kong

OTHER

lead

Hong Kong Children's Hospital

OTHER